Your browser is no longer supported. Please, upgrade your browser.
Settings
OCGN [NASD]
Ocugen, Inc.
Index- P/E- EPS (ttm)-0.33 Insider Own0.50% Shs Outstand198.23M Perf Week-3.67%
Market Cap1.38B Forward P/E12.63 EPS next Y0.54 Insider Trans-50.45% Shs Float192.50M Perf Month-19.39%
Income-37.50M PEG- EPS next Q-0.03 Inst Own13.00% Short Float27.14% Perf Quarter-42.98%
Sales0.04M P/S32360.60 EPS this Y79.00% Inst Trans4.52% Short Ratio1.12 Perf Half Y274.73%
Book/sh0.25 P/B27.28 EPS next Y550.00% ROA-119.50% Target Price5.38 Perf Year1055.93%
Cash/sh0.22 P/C30.79 EPS next 5Y- ROE-154.50% 52W Range0.25 - 18.77 Perf YTD272.68%
Dividend- P/FCF- EPS past 5Y70.80% ROI- 52W High-63.77% Beta4.48
Dividend %- Quick Ratio12.00 Sales past 5Y- Gross Margin- 52W Low2618.91% ATR0.59
Employees15 Current Ratio12.00 Sales Q/Q- Oper. Margin- RSI (14)44.14 Volatility5.41% 8.27%
OptionableYes Debt/Eq0.05 EPS Q/Q49.30% Profit Margin- Rel Volume0.19 Prev Close6.82
ShortableYes LT Debt/Eq0.04 EarningsMay 07 BMO Payout- Avg Volume46.52M Price6.80
Recom2.70 SMA20-4.23% SMA50-11.45% SMA20022.80% Volume1,958,690 Change-0.29%
Jul-26-21Initiated Noble Capital Markets Outperform
Jun-11-21Downgrade ROTH Capital Buy → Neutral $10 → $6
May-07-21Downgrade Cantor Fitzgerald Overweight → Neutral
Feb-09-21Downgrade Chardan Capital Markets Buy → Neutral $0.70 → $13
Feb-04-21Upgrade H.C. Wainwright Neutral → Buy $4.50
Jul-30-21 08:45AM  
Jul-29-21 01:20PM  
12:40PM  
12:15PM  
11:18AM  
11:07AM  
11:00AM  
Jul-28-21 09:10PM  
08:00PM  
07:05PM  
02:35PM  
01:55PM  
01:09PM  
11:40AM  
11:35AM  
11:00AM  
11:00AM  
11:00AM  
10:15AM  
09:33AM  
Jul-27-21 01:30PM  
01:00PM  
11:58AM  
10:30AM  
09:00AM  
08:00AM  
05:40AM  
12:50AM  
Jul-26-21 09:15PM  
07:53PM  
04:32PM  
03:02PM  
02:50PM  
02:45PM  
02:00PM  
12:58PM  
11:30AM  
11:00AM  
07:35AM  
05:40AM  
Jul-25-21 11:00AM  
10:16AM  
Jul-23-21 08:52PM  
02:00PM  
01:30PM  
11:40AM  
11:00AM  
Jul-22-21 02:20PM  
01:00PM  
01:00PM  
11:00AM  
11:00AM  
05:27AM  
Jul-21-21 09:30PM  
08:47PM  
08:00PM  
02:00PM  
01:10PM  
11:45AM  
11:40AM  
11:00AM  
Jul-20-21 05:15PM  
03:45PM  
02:08PM  
12:40PM  
12:35PM  
11:00AM  
10:00AM  
09:45AM  
08:30AM  
05:40AM  
Jul-19-21 08:07PM  
05:33PM  
05:20PM  
04:00PM  
03:51PM  
02:30PM  
11:35AM  
11:00AM  
05:31AM  
01:00AM  
Jul-18-21 10:30AM  
Jul-16-21 09:48PM  
05:44PM  
04:59PM  
04:17PM  
03:43PM  
02:00PM  
12:18PM  
10:45AM  
Jul-15-21 08:17PM  
06:45PM  
03:05PM  
02:15PM  
01:41PM  
12:12PM  
11:45AM  
11:35AM  
11:00AM  
07:34AM  
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kumar RameshDirectorJul 19Option Exercise0.517,5003,8257,500Jul 21 04:04 PM
Kumar RameshDirectorJul 19Sale6.407,50048,0000Jul 21 04:04 PM
Subramanian SanjayChief Financial OfficerJul 15Option Exercise0.3431,08610,56976,677Jul 16 04:01 PM
Subramanian SanjayChief Financial OfficerJul 15Sale6.7031,086208,27645,591Jul 16 04:01 PM
Kompella UdayDirectorJun 25Option Exercise1.8310,00018,300560,674Jun 25 04:17 PM
Kompella UdayDirectorJun 25Sale8.1310,00081,345550,674Jun 25 04:17 PM
Subramanian SanjayChief Financial OfficerJun 15Option Exercise0.3431,00010,54076,591Jun 17 05:25 PM
Subramanian SanjayChief Financial OfficerJun 15Sale7.0031,000217,00045,591Jun 17 05:25 PM
Potti ManishDirectorJun 15Sale8.8668,185604,11991,124Jun 17 05:23 PM
Musunuri ShankarChief Executive OfficerJun 08Option Exercise0.3322,8007,524428,800Jun 09 07:22 PM
Musunuri ShankarChief Executive OfficerJun 08Sale10.9822,800250,344406,000Jun 09 07:22 PM
Musunuri ShankarChief Executive OfficerJun 07Option Exercise0.337,7582,560413,758Jun 09 07:22 PM
Musunuri ShankarChief Executive OfficerJun 07Sale10.947,75884,873406,000Jun 09 07:22 PM
Castillo KirstenDirectorJun 07Sale10.0010,000100,00065,000Jun 09 07:21 PM
Kompella UdayDirectorMay 28Option Exercise1.887,19113,519557,865Jun 01 06:10 AM
Kompella UdayDirectorMay 28Sale8.827,19163,417550,674Jun 01 06:10 AM
Fernandes PrabhavathiDirectorMay 25Option Exercise0.9333,50031,08019,500May 27 04:07 PM
Fernandes PrabhavathiDirectorMay 25Sale8.2033,500274,7550May 27 04:07 PM
Subramanian SanjayChief Financial OfficerMay 14Option Exercise0.3431,00010,54076,591May 14 04:58 PM
Subramanian SanjayChief Financial OfficerMay 14Sale8.1831,000253,67345,591May 14 04:58 PM
Tammara VijaySenior Vice PresidentMay 04Option Exercise0.8115,71112,7556,500May 05 08:15 PM
Tammara VijaySenior Vice PresidentMay 04Sale13.6815,711214,9540May 05 08:15 PM
Musunuri ShankarChief Executive OfficerMay 03Option Exercise0.51195,80999,863601,809May 03 09:00 PM
Tammara VijaySenior Vice PresidentMay 03Option Exercise0.464,3171,9864,317May 03 08:53 PM
Potti ManishDirectorMay 03Sale15.0260,000901,20063,429May 05 08:13 PM
Potti ManishDirectorMay 03Sale15.0128,000420,2800May 05 08:13 PM
Tammara VijaySenior Vice PresidentMay 03Sale16.004,31769,0720May 03 08:53 PM
Kompella UdayDirectorMay 03Sale15.0150,000750,500550,674May 03 09:05 PM
Musunuri ShankarChief Executive OfficerMay 03Sale14.24195,8092,788,320406,000May 03 09:00 PM
Kompella UdayDirectorApr 30Option Exercise0.5120,00010,200620,674May 03 09:05 PM
Kompella UdayDirectorApr 30Sale11.5620,000231,200600,674May 03 09:05 PM
Tammara VijaySenior Vice PresidentApr 29Option Exercise0.7529,99122,44212,880May 03 08:53 PM
Subramanian SanjayChief Financial OfficerApr 29Option Exercise2.197,99017,49853,581May 03 09:06 PM
Subramanian SanjayChief Financial OfficerApr 29Sale10.987,99087,73045,591May 03 09:06 PM
Tammara VijaySenior Vice PresidentApr 29Sale10.9729,991328,8810May 03 08:53 PM
Kompella UdayDirectorApr 26Sale11.70350,0004,095,000600,674Apr 28 06:52 PM
Kumar RameshDirectorApr 19Option Exercise0.517,5003,8257,500Apr 21 04:16 PM
Kumar RameshDirectorApr 19Sale5.337,50039,9750Apr 21 04:16 PM
Potti ManishDirectorMar 05Option Exercise0.8428,00023,52028,000Mar 08 08:38 PM
Subramanian SanjayChief Financial OfficerJan 29Option Exercise0.5135,59118,15145,591Feb 01 05:31 PM